Integrated Investment Consultants, LLC Catalent, Inc. Transaction History

Integrated Investment Consultants, LLC

$4.71 Billion
Q4 2024

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 Jul 18, 2023	BUY	$45.44 - $74.26 $166,492 - $272,088	3,664 New	3,664 $240,000
Q4 2022 Feb 13, 2023	SELL	$41.39 - $81.0 $3,725 - $7,290	-90 Reduced 1.36%	6,540 $294,000
Q3 2022 Nov 21, 2022	BUY	$72.36 - $113.1 $8,466 - $13,232	117 Added 1.8%	6,630 $480,000
Q2 2022 Jul 19, 2022	BUY	$87.2 - $114.05 $1,569 - $2,052	18 Added 0.28%	6,513 $699,000
Q1 2022 May 16, 2022	BUY	$94.19 - $124.49 $14,411 - $19,046	153 Added 2.41%	6,495 $720,000
Q4 2021 Jan 10, 2022	SELL	$119.57 - $139.07 $160,343 - $186,492	-1,341 Reduced 17.45%	6,342 $812,000
Q3 2021 Oct 28, 2021	BUY	$109.17 - $142.35 $8,733 - $11,388	80 Added 1.05%	7,683 $1.02 Million
Q2 2021 Jul 21, 2021	BUY	$100.34 - $115.69 $40,537 - $46,738	404 Added 5.61%	7,603 $822,000
Q1 2021 Apr 20, 2021	BUY	$101.51 - $125.27 $42,431 - $52,362	418 Added 6.16%	7,199 $758,000
Q4 2020 Feb 09, 2021	SELL	$85.88 - $105.36 $74,543 - $91,452	-868 Reduced 11.35%	6,781 $706,000
Q3 2020 Oct 26, 2020	BUY	$72.74 - $92.5 $219,092 - $278,610	3,012 Added 64.96%	7,649 $655,000
Q2 2020 Aug 04, 2020	SELL	$48.02 - $79.04 $27,179 - $44,736	-566 Reduced 10.88%	4,637 $340,000
Q1 2020 May 22, 2020	BUY	$36.95 - $62.95 $6,170 - $10,512	167 Added 3.32%	5,203 $270,000
Q4 2019 Jan 29, 2020	BUY	$47.06 - $56.64 $20,941 - $25,204	445 Added 9.69%	5,036 $284,000
Q3 2019 Oct 21, 2019	SELL	$47.45 - $58.05 $1,091 - $1,335	-23 Reduced 0.5%	4,591 $219,000
Q2 2019 Jul 16, 2019	BUY	$39.26 - $54.21 $181,145 - $250,124	4,614 New	4,614 $250,000
Q1 2019 Apr 26, 2019	SELL	$29.84 - $43.92 $215,146 - $316,663	-7,210 Closed	0 $0
Q4 2018 Feb 04, 2019	SELL	$29.95 - $46.34 $7,577 - $11,724	-253 Reduced 3.39%	7,210 $225,000
Q3 2018 Oct 29, 2018	BUY	$40.12 - $45.55 $12,958 - $14,712	323 Added 4.52%	7,463 $340,000
Q2 2018 Aug 01, 2018	SELL	$38.72 - $42.52 $1,122 - $1,233	-29 Reduced 0.4%	7,140 $299,000
Q1 2018 Apr 12, 2018	BUY	$39.4 - $47.39 $8,904 - $10,710	226 Added 3.26%	7,169 $294,000
Q3 2017 Oct 26, 2017	BUY	$33.75 - $41.67 $234,326 - $289,314	6,943	6,943 $277,000

Others Institutions Holding CTLT

# of Institutions

319

Shares Held

114M

Call Options Held

571K

Put Options Held

2.03M

Black Rock Inc. New York, NY

15.4M
Shares

$975 Million
0.02% of portfolio
State Street Corp Boston, MA

7.45M
Shares

$473 Million
0.02% of portfolio
Capital World Investors Los Angeles, CA

6.4M
Shares

$406 Million
0.06% of portfolio
Israel Englander Millennium Management LLC | New York, Ny

4.52M
Shares

$287 Million
0.14% of portfolio
Barclays PLC London, X0

4.28M
Shares

$272 Million
0.07% of portfolio

View Full List

About Catalent, Inc.

Ticker CTLT
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 179,896,000
Market Cap $11.4B
Description
Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products,...

More about CTLT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Integrated Investment Consultants, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Integrated Investment Consultants, LLC with notifications on news.

Account